HeXun Biosciences , Ltd. Total Current Liabilities

HeXun Biosciences , Ltd. (6986.TWO) currently reports a total current liabilities of $79M as of June 2026. That compares with $68M in the prior-year period — up 15.4% year over year. Use the charts on this page to explore HeXun Biosciences , Ltd.'s total current liabilities history and peer comparisons.

HeXun Biosciences , Ltd.'s total current liabilities increased from $68M to $79M — a 15.4% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HeXun Biosciences , Ltd. reported $79M in total current liabilities as of June 2026. That compares with $68M in the prior-year period — up 15.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $79M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for HeXun Biosciences , Ltd., and consider following 6986.TWO for alerts when major investors trade the stock.

HeXun Biosciences , Ltd. is classified in the Healthcare sector. On total current liabilities, it currently shows $79M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6986.TWO with unrelated industries.